About Biotech-IgG
Biotech IgG AG provides products for research, routine, and process scale purposes to biotechnology and medical immunodiagnostics markets. It offers products for use in existing manufacturing processes and in the development of new processes, primarily in the protein production fields, involving techniques, such as cell culture, and resolution separation and purification. The company also provides kits and reagents for use in research and diagnostic laboratories. In addition, it offers contract consultancy services for market surveys; and project, process, and product design. Further, the company conducts market investigations, as well as undertakes contract research and process development. Biotech IgG offers its products and services in Scandinavia, Britain, Finland, the United States, and Sweden. The company was founded in 1989 and is based in Lund, Sweden. As of April 1, 2009, Biotech IgG AG operates as a subsidiary of Chemel AB.
- Focus : Manufacturer
- Industry : Laboratory analysis / Laboratory measurement technology
Product portfolio of Biotech-IgG
Similar companies
Here you will find Biotech-IgG AB
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
